The Ibn Sina Pharmaceutical Industry's profit grew marginally in the second quarter of fiscal year 2024-25. The company's profit stood at Tk 21.08 crore in Q2. Shares of the company went up 0.24 ...
Some results have been hidden because they may be inaccessible to you